Gut microbiota plays a major role in the cancer microenvironment associated with immune checkpoint blockade. Recent developments in gut microbiota research have benefited from technological innovations by next-generation sequencers, and the research has exploded. Therefore, we considered gut microbiota from the viewpoint of antitumor and adverse events of immune checkpoint inhibitors.